SEC Filing Details
SEC Filing Details
Document Details
Form
Filing Date
Feb 14, 2025
Document Date
Feb 14, 2025
Form Description
SCHEDULE 13G/A - Description
Company
Akebia Therapeutics
Issuer
Akebia Therapeutics, Inc.
Print Page
Email Page
Contact IR
Email Alerts
Tear Sheet
Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142
+1 617.871.2098 phone
+1 617.871.2099 fax